Dimensional Fund Advisors
LXRX icon

Dimensional Fund Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Dimensional Fund Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,966
Closed -$48K – 3342
2024
Q4 		$48K Sell
64,966
-11,120
-15% -$13.4K ﹤0.01% 3297
2024
Q3 		$119K Hold
76,086
– – ﹤0.01% 3224
2024
Q2 		$128K Buy
76,086
+26,143
+52% +$46.9K ﹤0.01% 3219
2024
Q1 		$120K Buy
+49,943
New +$107K ﹤0.01% 3243
2023
Q4 		– Sell
-310,815
Closed -$339K – 3439
2023
Q3 		$339K Sell
310,815
-432,922
-58% -$760K ﹤0.01% 3116
2023
Q2 		$1.7M Buy
743,737
+24,555
+3% +$65.2K ﹤0.01% 2821
2023
Q1 		$1.75M Buy
+719,182
New +$1.65M ﹤0.01% 2770
2022
Q3 		$1.11M Sell
463,188
-201,600
-30% -$558K ﹤0.01% 2857
2022
Q2 		$1.24M Sell
664,788
-204,823
-24% -$391K ﹤0.01% 2878
2022
Q1 		$1.82M Buy
869,611
+96,633
+13% +$268K ﹤0.01% 2855
2021
Q4 		$3.05M Buy
772,978
+277,540
+56% +$1.35M ﹤0.01% 2731
2021
Q3 		$2.38M Sell
495,438
-46,217
-9% -$190K ﹤0.01% 2810
2021
Q2 		$2.49M Buy
+541,655
New +$2.61M ﹤0.01% 2817
2021
Q1 		– Sell
-16,778
Closed -$57K – 3420
2020
Q4 		$57K Buy
+16,778
New +$32K ﹤0.01% 3311
2020
Q2 		– Sell
-32,900
Closed -$64K – 3353
2020
Q1 		$64K Buy
32,900
+19,000
+137% +$56.6K ﹤0.01% 3303
2019
Q4 		$58K Buy
+13,900
New +$53.5K ﹤0.01% 3341
2016
Q2 		– Sell
-31,101
Closed -$372K – 3301
2016
Q1 		$372K Sell
31,101
-2,501
-7% -$26.2K ﹤0.01% 3093
2015
Q4 		$447K Hold
33,602
– – ﹤0.01% 3110
2015
Q3 		$361K Hold
33,602
– – ﹤0.01% 3173
2015
Q2 		$270K Buy
+33,602
New +$247K ﹤0.01% 3217

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors's LXRX Position: Q1 2025 in Review

Dimensional Fund Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2025, closing a stake of 64,966 shares — an estimated $48K sold.

Dimensional Fund Advisors first reported a position in LXRX in Q2 2015 and held it in 20 quarters. The position peaked at $3.05M in Q4 2021. 127 funds tracked by Wall St. Rank hold LXRX as of Q1 2025.

  • Dimensional Fund Advisors reported no remaining Lexicon Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 64,966 Lexicon Pharmaceuticals shares in Q1 2025, an estimated $48K.
  • Dimensional Fund Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • Dimensional Fund Advisors's Lexicon Pharmaceuticals position peaked at $3.05M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2025.

Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.